title: Adiponectin and its receptors in chronic hepatitis B patients with steatosis in china.
abstract: BACKGROUND
  HBV infection is a serious public health problem worldwide, which can contribute to the incidence of chronic hepatitis B (CHB), cirrhosis, and hepatocellular carcinoma (HCC).
  
  
  OBJECTIVE
  In the present report, we assessed the association between adiponectin, its receptors and hepatic steatosis, fibrosis, and inflammation with hepatitis B virus.
  
  
  METHODS
  Liver biopsies from 89 patients with untreated chronic hepatitis B (34 steatosis vs. 55 without steatosis) were analyzed; liver biopsies from 50 healthy adults were used as control. The liver biopsies were subjected to routine histological examination, and stained immunohistochemically for adiponectin and adiponectin receptor2 (adipoR2).
  
  
  RESULTS
  The two groups were found to be comparable with respect to demographic, biochemical, metabolic, histological, and viral characteristics. BMI, γ-GT, FPG, insulin, and insulin sensitivity estimated by the HOMA index were significantly higher in patients with steatosis. The viral load of HBV and HBeAg positivity was higher in patients with steatosis than those without steatosis. High serum adiponectin levels were significantly correlated with abnormal serum ALT level (vs. normal ALT, P = 0.000), and HBV genotype C (vs. genotype B, P = 0.018). In patients with chronic HBV, the insulin sensitizing adipokine adiponectin, and its receptor AdipoR2were associated with steatosis. While adiponectin may becorrelated with inflammation, adiponectin, and its receptors were not associated with viral factors.
  
  
  CONCLUSIONS
  Our results suggest that the role of adiponectin might be impaired in chronic hepatitis B with steatosis. Reduced hepatic expression of adiponectin and adipoR2 might be of pathophysiological relevance in CHB patients with steatosis. These findings indicated that reduced liver adiponectin expression may play an important role in the pathogenesis, and progression of CHB patients with steatosis. However, hepatic expression of adiponectin, and adipoR2 was not associated with various measures of HBV infection.
authors.affiliation: Department of Ultrasound, Air Force General Hospital of PLA, Beijing, China.
authors.forename: Di
authors.initials: D
authors.lastname: Wu
authors.forename: Hongqi
authors.initials: H
authors.lastname: Li
authors.forename: Guoan
authors.initials: G
authors.lastname: Xiang
authors.forename: Liwei
authors.initials: L
authors.lastname: Zhang
authors.forename: Lihong
authors.initials: L
authors.lastname: Li
authors.forename: Yongmei
authors.initials: Y
authors.lastname: Cao
authors.forename: Jinqian
authors.initials: J
authors.lastname: Zhang
keywords: Adiponectin; Hepatitis B, Chronic; Receptors, Adiponectin; liver
references.citation: Trends Endocrinol Metab. 2002 Mar;13(2):84-9
references.pmid: 11854024
references.citation: Hepatology. 2008 Aug;48(2):458-73
references.pmid: 18666257
references.citation: Am J Physiol Endocrinol Metab. 2004 Jul;287(1):E82-9
references.pmid: 15010338
references.citation: Hepatology. 2004 Jul;40(1):46-54
references.pmid: 15239085
references.citation: Gastroenterology. 2003 Dec;125(6):1796-807
references.pmid: 14724832
references.citation: J Hepatol. 1991 Nov;13(3):372-4
references.pmid: 1808228
references.citation: J Gastrointestin Liver Dis. 2008 Jun;17(2):147-54
references.pmid: 18568135
references.citation: Hepatology. 1990 Jan;11(1):74-80
references.pmid: 2295475
references.citation: Gut. 2005 Jan;54(1):117-21
references.pmid: 15591515
references.citation: Diabetes. 2003 May;52(5):1182-6
references.pmid: 12716750
references.citation: Circulation. 2001 Feb 27;103(8):1057-63
references.pmid: 11222466
references.citation: Diabetologia. 1985 Jul;28(7):412-9
references.pmid: 3899825
references.citation: J Clin Endocrinol Metab. 2005 Apr;90(4):2240-3
references.pmid: 15644404
references.citation: Diabetes Care. 2000 Jan;23(1):57-63
references.pmid: 10857969
references.citation: J Gastroenterol Hepatol. 2003 Apr;18(4):386-92
references.pmid: 12653886
references.citation: Blood. 2000 Sep 1;96(5):1723-32
references.pmid: 10961870
references.citation: J Hepatol. 1995 Jun;22(6):696-9
references.pmid: 7560864
references.citation: J Hepatol. 2005 Dec;43(6):929-36
references.pmid: 16139921
references.citation: Trends Endocrinol Metab. 2002 Jan-Feb;13(1):18-23
references.pmid: 11750858
references.citation: Biochem Biophys Res Commun. 2004 Oct 15;323(2):630-5
references.pmid: 15369797
references.citation: Nat Med. 2001 Aug;7(8):947-53
references.pmid: 11479628
references.citation: Hepatology. 2004 May;39(5):1230-8
references.pmid: 15122751
references.citation: J Clin Invest. 2003 Jul;112(1):91-100
references.pmid: 12840063
references.citation: Diabetes. 2003 Feb;52(2):239-43
references.pmid: 12540592